XAV939 Improves the Prognosis of Myocardial Infarction by Blocking the Wnt/β-Catenin Signalling Pathway

MLA

Zhu Zhang, et al. “XAV939 Improves the Prognosis of Myocardial Infarction by Blocking the Wnt/β-Catenin Signalling Pathway.” Applied Biochemistry and Biotechnology, May 2023. EBSCOhost, https://doi.org/10.1007/s12010-023-04485-y.

APA

Zhu Zhang, Jiancheng Qi, Xiucai Fan, & Min Pan. (2023). XAV939 Improves the Prognosis of Myocardial Infarction by Blocking the Wnt/β-Catenin Signalling Pathway. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-023-04485-y

Chicago

Zhu Zhang, Jiancheng Qi, Xiucai Fan, and Min Pan. 2023. “XAV939 Improves the Prognosis of Myocardial Infarction by Blocking the Wnt/β-Catenin Signalling Pathway.” Applied Biochemistry and Biotechnology, May. doi:10.1007/s12010-023-04485-y.